Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

To investigate if MS and HC differ in how 25(OH)D3 is associated with PFAS and OH-PCBs, Spearmans’ rank correlation analyses, regardless of disease, as well as separated on disease, were made.

Source: PFAS levels correlate with vitamin D3 levels. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Case-control study.

Case-control study

Compares people with an outcome against people without it, examining exposures.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This study is based on the Swedish population-based case-control study EIMS.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Associations of PFAS and OH-PCBs with risk of multiple sclerosis onset and disability worsening

Case-control study · Nature Communications · 2025

Original publication title

Associations of PFAS and OH-PCBs with risk of multiple sclerosis onset and disability worsening

Aina Vaivade; Ida Erngren; Henrik Carlsson; Eva Freyhult; Payam Emami Khoonsari; Yassine Noui; Asma Al-Grety; Torbjörn Åkerfeldt; Ola Spjuth; Valentina Gallo; Anders Olof Larsson; Ingrid Kockum; Anna Karin Hedström; Lars Alfredsson; Tomas Olsson; Joachim Burman; Kim Kultima

© The Author(s) 2025

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Exposure to per: and polyfluorinated substances (PFAS) and hydroxylated polychlorinated biphenyls (OH-PCBs) is associated with adverse human health effects, including immunosuppression. It is unknown if these substances can affect the course of autoimmune diseases. This study was based on 907 individuals with multiple sclerosis (MS) and 907 matched controls, where the MS cases were followed longitudinally using the Swedish MS register. We demonstrate sex: and disease-specific differences in serum PFAS concentrations between individuals with MS and controls. Moreover, two OH-PCBs (4-OH-CB187 and 3-OH-CB153) are associated with an increased risk of developing multiple sclerosis, regardless of sex and immigration status.

With a clinical follow-up time of up to 18 years, an increase in serum concentrations of perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorodecanoic acid (PFDA) decreases the risk of confirmed disability worsening in both sexes, as well as perfluoroheptanesulfonic acid (PFHpS) and perfluorononanoic acid (PFNA), only in males with MS. These results show previously unknown associations between OH-PCBs and the risk of developing MS, as well as the inverse associations between PFAS exposure and the risk of disability worsening in MS.

PFAS and OH-PCBs are associated with health effects. Here, the authors present an association between OH-PCB exposure and increased risk of multiple sclerosis, while increased PFAS levels were associated with reduced risk of disability worsening.

Authors’ abstract

Exposure to per: and polyfluorinated substances (PFAS) and hydroxylated polychlorinated biphenyls (OH-PCBs) is associated with adverse human health effects, including immunosuppression. It is unknown if these substances can affect the course of autoimmune diseases. This study was based on 907 individuals with multiple sclerosis (MS) and 907 matched controls, where the MS cases were followed longitudinally using the Swedish MS register. We demonstrate sex: and disease-specific differences in serum PFAS concentrations between individuals with MS and controls. Moreover, two OH-PCBs (4-OH-CB187 and 3-OH-CB153) are associated with an increased risk of developing multiple sclerosis, regardless of sex and immigration status.

With a clinical follow-up time of up to 18 years, an increase in serum concentrations of perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorodecanoic acid (PFDA) decreases the risk of confirmed disability worsening in both sexes, as well as perfluoroheptanesulfonic acid (PFHpS) and perfluorononanoic acid (PFNA), only in males with MS. These results show previously unknown associations between OH-PCBs and the risk of developing MS, as well as the inverse associations between PFAS exposure and the risk of disability worsening in MS.

PFAS and OH-PCBs are associated with health effects. Here, the authors present an association between OH-PCB exposure and increased risk of multiple sclerosis, while increased PFAS levels were associated with reduced risk of disability worsening.

Publication and source details

Original title: Associations of PFAS and OH-PCBs with risk of multiple sclerosis onset and disability worsening

Aina Vaivade; Ida Erngren; Henrik Carlsson; Eva Freyhult; Payam Emami Khoonsari; Yassine Noui; Asma Al-Grety; Torbjörn Åkerfeldt; Ola Spjuth; Valentina Gallo; Anders Olof Larsson; Ingrid Kockum; Anna Karin Hedström; Lars Alfredsson; Tomas Olsson; Joachim Burman; Kim Kultima

Nature Communications · 2025

© The Author(s) 20252025https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.https://doi.org/10.13039/501100004359Vetenskapsrådet (Swedish Research Council)2021 to 02189 and 2024-031612021 to 02814Burman Joachim Kultima Kim https://doi.org/10.13039/501100001862Svenska Forskningsrådet Formas (Swedish Research Council Formas)2020 to 01267 and 2023-00905Kultima Kim NEURO Sweden, Region Uppsala (ALF-grant and R&D funds), and Åke WibergThe Swedish Foundation for MS ResearchForte (2024-01410)Knut and Alice Wallenberg Foundation (grants: KAW 2020.0239 and KAW 2017.0003)https://doi.org/10.13039/501100003748Svenska Sällskapet för Medicinsk Forskning (Swedish Society for Medical Research)The Marianne and Marcus Wallenberg Foundation, Region Uppsala (ALF-grant and R&D funds)

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T06:36:23.247399+00:00

DOI: 10.1038/s41467-025-57172-3 · PMC11868641